查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092960

伴侶動物延壽市場預測至2034年－按產品類型、動物種類、技術、應用、最終使用者和地區分類的全球分析

Companion Animal Life Extension Market Forecasts to 2034 - Global Analysis By Product Type, Animal Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球伴侶動物延壽市場規模將達到 32 億美元，並在預測期內以 14.2% 的複合年成長率成長，到 2034 年將達到 93 億美元。

伴侶動物延壽是指透過應用預防保健、先進獸醫學、營養管理、遺傳學知識、再生醫學和生活方式調整等手段，延長伴侶動物的壽命並改善其長期健康。它著重於透過實證治療策略延緩與老齡化相關的衰退、預防疾病並維持其生理和認知功能。伴侶動物延壽整合了持續的健康監測和個人化的治療方案，旨在提高寵物的壽命、生活品質和整體福祉。

寵物「擬人化」的趨勢

隨著寵物飼主與寵物之間情感紐帶的加深，延長寵物壽命相關產品和服務的需求顯著成長。寵物飼主越來越將心愛的寵物視為家庭成員，並願意在預防性醫療保健和長壽干預措施上投入大量資金。這種「人性化」趨勢也延伸到了營養領域，飼主尋求針對特定生命階段和健康狀況配製的優質食品。在已開發市場，終端使用者在獸醫檢查、診斷篩檢和特殊治療方面的支出持續成長。隨著寵物健康監測技術融入日常生活，預防性長壽管理正變得越來越普遍。

監理不確定性

伴侶動物長壽產品監管環境的不斷變化對市場發展構成重大障礙。包括基因療法和細胞療法在內的新型療法在許多司法管轄區都面臨著漫長且充滿不確定性的核准流程。營養保健品和膳食補充劑的監管相對寬鬆，導致產品品質參差不齊，消費者普遍持懷疑態度。由於缺乏衡量延長壽命效果的標準化療效指標，產品差異化和市場推廣都面臨挑戰。這些監管難題要求產品開發商投入大量臨床資源並保持耐心。

基因檢測的普及

經濟實惠的伴侶動物基因檢測的廣泛普及，為拓展個人化長壽干預市場提供了巨大機會。基因圖譜揭示了特定品種的疾病易感性、藥物敏感性和最佳營養需求，有助於制定預防性醫療保健策略。面向消費者的直接檢測套組使基因組資訊更容易獲取，從而催生了寵物飼主。獸醫診所正在利用基因數據來客製化疫苗接種計劃、篩檢方案和飲食建議。檢測實驗室與治療藥物研發公司之間的合作正在建構一個整合的、精準的長壽生態系統。

對景氣衰退的敏感性

寵物延壽產品屬於可自由支配支出，在景氣衰退時期，消費者往往會削減這方面的開支。當家庭預算緊張時，高階營養食品、特殊療法和先進診斷服務的需求彈性會降低。來自基礎獸醫護理和非專利藥​​的競爭威脅著高階延壽產品的市場地位。保險對預防性和選擇性延壽治療的保障範圍有限，也限制了目標市場規模。由於寵物延壽相關支出屬於可自由支配支出，因此極易受到宏觀經濟週期的影響。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了寵物飼養的普及，擴大了延長寵物壽命產品的潛在市場。封鎖措施加深了飼主與寵物之間的情感紐帶，也提高了人們對寵物健康和福祉的投入意願。然而，獸醫診所的營運限制暫時阻礙了人們獲得預防性護理服務和診斷檢測。疫情過後，寵物飼養量的增加和人們健康意識的提高，持續推動對延長寵物壽命產品和服務的需求。

在預測期內，營養保健品和補充劑領域預計將佔據最大的市場佔有率。

由於其廣泛的消費管道、已確立的安全標準以及作為預防性藥物的定位，營養保健品和補充劑領域預計將在預測期內佔據最大的市場佔有率。諸如ω脂肪酸、葡萄糖胺、益生菌、抗氧化劑和特殊維生素等營養保健品，能夠解決伴侶動物通用的與老齡化相關的健康問題。該領域受益於透過獸醫診所、寵物專賣店和電商管道作為非處方藥進行銷售。消費者對人類營養補充品的認知不斷提高，也促使人們對寵物專用類似產品接受度不斷提升。大型寵物食品製造商和製藥公司擁有豐富的營養補充品產品線，並具備很高的品牌知名度。

在預測期內，狗類產品細分市場預計將呈現最高的複合年成長率。

在預測期內，犬類市場預計將呈現最高的成長率，這主要得益於寵物飼養量的增加、醫療保健投入的擴大以及對以延長壽命為重點的獸醫解決方案需求的成長。個人化營養管理、再生醫學、基因篩檢和持續健康監測的日益普及正在加速市場擴張。犬類老齡化相關疾病發生率的上升以及飼主對先進健康計劃投資意願的增強，進一步推動了市場成長，使犬類成為伴侶動物延壽市場中成長最快的細分領域。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其較高的寵物擁有率、完善的獸醫基礎設施以及消費者在伴侶動物健康方面不斷成長的支出。美國憑藉其龐大的專科獸醫醫院網路和先進的診斷能力，以及對寵物長壽保障政策的支持，在市場中處於領先地位。加拿大則憑藉其先進的動物福利政策和資金充足的寵物保險市場做出貢獻。較高的可支配收入以及將寵物視為人類的文化正在推動對高級產品的需求。碩騰（Zoetis）、禮來（Elanco）和雀巢普瑞納（Nestlé Purina）等領先企業在全部區域保持顯著的市場佔有率。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於寵物擁有量的快速成長以及人們對伴侶動物醫療保健投資意願的不斷提高。中國和日本是關鍵的成長市場，這主要得益於中產階級寵物擁有量的增加以及獸醫護理標準的現代化。韓國和澳洲在高階營養和預防性護理方面的人均支出較高。都市區寵物飼主對先進獸醫護理的認知不斷提高，正在加速其普及應用。此外，該地區蓬勃發展的生技產業也為當地再生醫學研究提供了支持。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球伴侶動物延壽市場：依產品類型分類

  • Longevity Therapeutics
  • 營養保健品和補充劑
  • 精準營養產品
  • 再生醫學產品
  • 基因檢測解決方案
  • 細胞治療產品
  • 抗老藥物

第6章：全球伴侶動物延壽市場：依動物類型分類

  • 狗
  • 貓
  • 鳥
  • 小型哺乳動物
  • 爬蟲類
  • 其他

第7章 全球伴侶動物延壽市場：依技術分類

  • 基因組學
  • 幹細胞療法
  • 基因治療
  • 人工智慧
  • 生物標記分析
  • 精準醫療

第8章：全球伴侶動物延壽市場：依應用領域分類

  • 健康老化
  • 慢性病管理
  • 預防性醫療保健
  • 免疫功能改善
  • 認知健康
  • 運動功能與關節健康

第9章 全球伴侶動物延壽市場：依最終用戶分類

  • 寵物飼主
  • 獸醫專家
  • 動物研究機構
  • 寵物健康中心
  • 動物康復中心
  • 繁殖設施

第10章：全球伴侶動物延壽市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Elanco Animal Health Incorporated
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Nestle Purina PetCare
  • Mars Petcare
  • Hill's Pet Nutrition
  • Basepaws
  • Loyal, Inc.
  • Dog Aging Project
  • Gero PTE. Ltd.
  • AnimalBiome
  • Ceva Sante Animale
  • Vetoquinol SA
  • Virbac SA
  • Dechra Pharmaceuticals PLC
Product Code: SMRC38129

According to Stratistics MRC, the Global Companion Animal Life Extension Market is accounted for $3.2 billion in 2026 and is expected to reach $9.3 billion by 2034 growing at a CAGR of 14.2% during the forecast period. Companion Animal Life Extension refers to the application of preventive healthcare, advanced veterinary medicine, nutritional management, genetic insights, regenerative therapies, and lifestyle interventions to increase the lifespan and improve the long-term health of companion animals. It focuses on delaying age-related decline, preventing disease, and maintaining physical and cognitive function through evidence-based care strategies. Companion animal life extension integrates continuous health monitoring and personalized treatment approaches to enhance longevity, quality of life, and overall well-being in pets.

Market Dynamics:

Driver:

Pet humanization trends

The deepening emotional bond between pet owners and their companion animals is driving substantial demand for life extension products and services. Pet owners increasingly view their animals as family members and are willing to invest significantly in preventive healthcare and longevity interventions. The humanization trend extends to nutrition, where owners seek premium diets formulated for specific life stages and health conditions. End-user spending on veterinary wellness exams, diagnostic screenings, and specialty therapeutics continues to rise across developed markets. The integration of pet health monitoring technologies into daily routines normalizes proactive longevity management.

Restraint:

Regulatory uncertainty

The evolving regulatory landscape for companion animal longevity products presents significant barriers to market development. Novel therapeutics, including gene therapies and cell-based treatments, face lengthy approval processes with unclear pathways in many jurisdictions. Nutraceutical and supplement categories operate with less stringent oversight, creating quality variability and consumer skepticism. The absence of standardized efficacy metrics for life extension claims complicates product differentiation and marketing. These regulatory challenges necessitate substantial clinical investment and patience from product developers.

Opportunity:

Genetic testing expansion

The proliferation of affordable companion animal genetic testing presents transformative market expansion opportunities for personalized longevity interventions. Genetic profiles reveal breed-specific disease predispositions, drug sensitivities, and optimal nutritional requirements that inform preventive care strategies. Direct-to-consumer testing kits have democratized access to genomic information, creating educated pet owners who demand targeted interventions. Veterinary practices leverage genetic data to customize vaccination schedules, screening protocols, and dietary recommendations. Partnerships between testing laboratories and therapeutic developers create integrated precision longevity ecosystems.

Threat:

Economic downturn sensitivity

Companion animal life extension products represent discretionary expenditures that consumers reduce during economic contractions. Premium nutrition, specialty therapeutics, and advanced diagnostic services face demand elasticity when household budgets tighten. Competition from basic veterinary care and generic alternatives challenges the market position of premium longevity products. Insurance coverage limitations for preventive and elective longevity treatments restrict the addressable market size. The discretionary nature of pet longevity spending creates vulnerability to macroeconomic cycles.

Covid-19 Impact:

The COVID-19 pandemic accelerated companion animal adoption rates, expanding the addressable market for life extension products. Lockdown measures strengthened owner-animal bonds and increased willingness to invest in pet health and wellness. However, veterinary clinic restrictions temporarily limited access to preventive care services and diagnostic testing. Post-pandemic, the enlarged pet population and heightened health awareness support sustained demand for longevity-focused products and services.

The nutraceuticals and supplements segment is expected to be the largest during the forecast period

The nutraceuticals and supplements segment is expected to account for the largest market share during the forecast period, due to broad consumer accessibility, established safety profiles, and preventive health positioning. Nutraceutical products, including omega fatty acids, glucosamine, probiotics, antioxidants, and specialized vitamins, address common age-related concerns in companion animals. The segment benefits from over-the-counter availability through veterinary clinics, pet specialty retailers, and e-commerce channels. Growing consumer familiarity with human nutraceuticals translates to acceptance of similar products for pets. Major pet food and pharmaceutical companies maintain extensive nutraceutical portfolios with strong brand recognition.

The dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dogs segment is predicted to witness the highest growth rate, driven by increasing pet ownership, rising investment in preventive healthcare, and growing demand for longevity-focused veterinary solutions. Greater adoption of personalized nutrition, regenerative therapies, genetic screening, and continuous health monitoring is accelerating market expansion. The higher incidence of age-related conditions in dogs and stronger owner willingness to invest in advanced wellness programs further support growth, positioning dogs as the fastest-growing segment in the Companion Animal Life Extension Market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high pet ownership rates, strong veterinary infrastructure, and elevated consumer spending on companion animal health. The United States leads with extensive networks of specialty veterinary hospitals and advanced diagnostic capabilities supporting longevity interventions. Canada contributes through its progressive animal welfare policies and well-funded pet insurance market. High disposable incomes and cultural emphasis on pet humanization drive premium product demand. Major companies including Zoetis, Elanco, and Nestle Purina maintain significant market presence across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding pet ownership and increasing willingness to invest in companion animal healthcare. China and Japan represent major growth markets with growing middle-class pet ownership and the modernization of veterinary care standards. South Korea and Australia demonstrate high per-capita spending on premium nutrition and preventive care. Growing awareness of advanced veterinary therapeutics among urban pet owners accelerates adoption. The region's expanding biotechnology sector supports indigenous regenerative medicine research.

Key players in the market

Some of the key players in Companion Animal Life Extension Market include Zoetis Inc., IDEXX Laboratories, Inc., Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim Animal Health, Nestle Purina PetCare, Mars Petcare, Hill's Pet Nutrition, Basepaws, Loyal, Inc., Dog Aging Project, Gero PTE. Ltd., AnimalBiome, Ceva Sante Animale, Vetoquinol S.A., Virbac S.A. and Dechra Pharmaceuticals PLC.

Key Developments:

In June 2026, Ceva Sante Animale launched a novel longevity therapeutic platform targeting cellular senescence pathways in aging dogs, demonstrating extended healthspan in preclinical trials across multiple breeds.

In May 2026, Hill's Pet Nutrition secured a major contract deploying genetic testing and precision nutrition programs across North American veterinary hospital networks for personalized companion animal health management.

In April 2026, Virbac S.A. introduced a next-generation regenerative medicine product line featuring autologous stem cell therapies for osteoarthritis treatment in senior companion animals.

In March 2026, Loyal, Inc. expanded its microbiome analysis platform to include longevity-associated bacterial biomarkers, enabling early intervention for age-related metabolic decline in pets.

In February 2026, Boehringer Ingelheim Animal Health partnered with a leading veterinary research institute to conduct clinical trials on senolytic compounds for extending healthy lifespan in geriatric companion animals.

Product Types Covered:

  • Longevity Therapeutics
  • Nutraceuticals and Supplements
  • Precision Nutrition Products
  • Regenerative Medicine Products
  • Genetic Testing Solutions
  • Cell Therapy Products
  • Anti-Aging Pharmaceuticals

Animal Types Covered:

  • Dogs
  • Cats
  • Birds
  • Small Mammals
  • Reptiles
  • Others

Technologies Covered:

  • Genomics
  • Stem Cell Therapy
  • Gene Therapy
  • Artificial Intelligence
  • Biomarker Analysis
  • Precision Medicine

Applications Covered:

  • Healthy Aging
  • Chronic Disease Management
  • Preventive Healthcare
  • Immune Enhancement
  • Cognitive Health
  • Mobility and Joint Health

End Users Covered:

  • Pet Owners
  • Veterinary Professionals
  • Animal Research Institutes
  • Pet Wellness Centers
  • Animal Rehabilitation Centers
  • Breeding Facilities

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Companion Animal Life Extension Market, By Product Type

  • 5.1 Longevity Therapeutics
  • 5.2 Nutraceuticals and Supplements
  • 5.3 Precision Nutrition Products
  • 5.4 Regenerative Medicine Products
  • 5.5 Genetic Testing Solutions
  • 5.6 Cell Therapy Products
  • 5.7 Anti-Aging Pharmaceuticals

6 Global Companion Animal Life Extension Market, By Animal Type

  • 6.1 Dogs
  • 6.2 Cats
  • 6.3 Birds
  • 6.4 Small Mammals
  • 6.5 Reptiles
  • 6.6 Others

7 Global Companion Animal Life Extension Market, By Technology

  • 7.1 Genomics
  • 7.2 Stem Cell Therapy
  • 7.3 Gene Therapy
  • 7.4 Artificial Intelligence
  • 7.5 Biomarker Analysis
  • 7.6 Precision Medicine

8 Global Companion Animal Life Extension Market, By Application

  • 8.1 Healthy Aging
  • 8.2 Chronic Disease Management
  • 8.3 Preventive Healthcare
  • 8.4 Immune Enhancement
  • 8.5 Cognitive Health
  • 8.6 Mobility and Joint Health

9 Global Companion Animal Life Extension Market, By End User

  • 9.1 Pet Owners
  • 9.2 Veterinary Professionals
  • 9.3 Animal Research Institutes
  • 9.4 Pet Wellness Centers
  • 9.5 Animal Rehabilitation Centers
  • 9.6 Breeding Facilities

10 Global Companion Animal Life Extension Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Zoetis Inc.
  • 13.2 IDEXX Laboratories, Inc.
  • 13.3 Elanco Animal Health Incorporated
  • 13.4 Merck Animal Health
  • 13.5 Boehringer Ingelheim Animal Health
  • 13.6 Nestle Purina PetCare
  • 13.7 Mars Petcare
  • 13.8 Hill's Pet Nutrition
  • 13.9 Basepaws
  • 13.10 Loyal, Inc.
  • 13.11 Dog Aging Project
  • 13.12 Gero PTE. Ltd.
  • 13.13 AnimalBiome
  • 13.14 Ceva Sante Animale
  • 13.15 Vetoquinol S.A.
  • 13.16 Virbac S.A.
  • 13.17 Dechra Pharmaceuticals PLC

List of Tables

  • Table 1 Global Companion Animal Life Extension Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Companion Animal Life Extension Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Companion Animal Life Extension Market Outlook, By Longevity Therapeutics (2023-2034) ($MN)
  • Table 4 Global Companion Animal Life Extension Market Outlook, By Nutraceuticals and Supplements (2023-2034) ($MN)
  • Table 5 Global Companion Animal Life Extension Market Outlook, By Precision Nutrition Products (2023-2034) ($MN)
  • Table 6 Global Companion Animal Life Extension Market Outlook, By Regenerative Medicine Products (2023-2034) ($MN)
  • Table 7 Global Companion Animal Life Extension Market Outlook, By Genetic Testing Solutions (2023-2034) ($MN)
  • Table 8 Global Companion Animal Life Extension Market Outlook, By Cell Therapy Products (2023-2034) ($MN)
  • Table 9 Global Companion Animal Life Extension Market Outlook, By Anti-Aging Pharmaceuticals (2023-2034) ($MN)
  • Table 10 Global Companion Animal Life Extension Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 11 Global Companion Animal Life Extension Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 12 Global Companion Animal Life Extension Market Outlook, By Cats (2023-2034) ($MN)
  • Table 13 Global Companion Animal Life Extension Market Outlook, By Birds (2023-2034) ($MN)
  • Table 14 Global Companion Animal Life Extension Market Outlook, By Small Mammals (2023-2034) ($MN)
  • Table 15 Global Companion Animal Life Extension Market Outlook, By Reptiles (2023-2034) ($MN)
  • Table 16 Global Companion Animal Life Extension Market Outlook, By Others (2023-2034) ($MN)
  • Table 17 Global Companion Animal Life Extension Market Outlook, By Technology (2023-2034) ($MN)
  • Table 18 Global Companion Animal Life Extension Market Outlook, By Genomics (2023-2034) ($MN)
  • Table 19 Global Companion Animal Life Extension Market Outlook, By Stem Cell Therapy (2023-2034) ($MN)
  • Table 20 Global Companion Animal Life Extension Market Outlook, By Gene Therapy (2023-2034) ($MN)
  • Table 21 Global Companion Animal Life Extension Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
  • Table 22 Global Companion Animal Life Extension Market Outlook, By Biomarker Analysis (2023-2034) ($MN)
  • Table 23 Global Companion Animal Life Extension Market Outlook, By Precision Medicine (2023-2034) ($MN)
  • Table 24 Global Companion Animal Life Extension Market Outlook, By Application (2023-2034) ($MN)
  • Table 25 Global Companion Animal Life Extension Market Outlook, By Healthy Aging (2023-2034) ($MN)
  • Table 26 Global Companion Animal Life Extension Market Outlook, By Chronic Disease Management (2023-2034) ($MN)
  • Table 27 Global Companion Animal Life Extension Market Outlook, By Preventive Healthcare (2023-2034) ($MN)
  • Table 28 Global Companion Animal Life Extension Market Outlook, By Immune Enhancement (2023-2034) ($MN)
  • Table 29 Global Companion Animal Life Extension Market Outlook, By Cognitive Health (2023-2034) ($MN)
  • Table 30 Global Companion Animal Life Extension Market Outlook, By Mobility and Joint Health (2023-2034) ($MN)
  • Table 31 Global Companion Animal Life Extension Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Companion Animal Life Extension Market Outlook, By Pet Owners (2023-2034) ($MN)
  • Table 33 Global Companion Animal Life Extension Market Outlook, By Veterinary Professionals (2023-2034) ($MN)
  • Table 34 Global Companion Animal Life Extension Market Outlook, By Animal Research Institutes (2023-2034) ($MN)
  • Table 35 Global Companion Animal Life Extension Market Outlook, By Pet Wellness Centers (2023-2034) ($MN)
  • Table 36 Global Companion Animal Life Extension Market Outlook, By Animal Rehabilitation Centers (2023-2034) ($MN)
  • Table 37 Global Companion Animal Life Extension Market Outlook, By Breeding Facilities (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.